Across the U.S., there is a shortage of at least 14 cancer drugs, with the situation being particularly critical for two of them: cisplatin and carboplatin. These two platinum-based chemotherapy drugs are used extensively in cancer treatment, leading to heightened concern among doctors, patient groups and industry analysts.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,